Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Anthera Pharmaceuticals Inc | a13-20157_18k.htm |
Exhibit 16.1
September 4, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Anthera Pharmaceuticals, Inc.’s Form 8-K dated September 4, 2013, and we agree with the statements made therein.
Yours truly,
/s/ Deloitte and Touche LLP
San Francisco, CA